Australia Cardiovascular Disease Market Analysis

$3,000.00$7,500.00

  • Type: Therapeutics Area
  • Published : April 2021
  • Region: APAC
  • Country: Australia
  • Report ID : 4002

  • Format: PPT, PDF

Australian Cardiovascular Disease Market: Segmented by disease types (Hypertension, Hyperlipidaemia, Coronary Artery Disease, Arrhythmia, & Others), Drug Class (Anti-hyperlipidaemias, Anti-hypertensive, Anti-coagulants, Anti-arrhythmic, & Others), & by Distribution Channel (Hospital, Pharmacies, & Others)- Growth, Trends, and Forecast (2019 – 2028)

Clear
SKU: 4002 Categories: ,

Report Overview

The Australian Cardiovascular disease market size stood at around USD 10.4 billion in 2020 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

The rise in the prevalence of various coronary heart diseases such as stroke, cardiomyopathy causing cardiac deaths and favorable reimbursement initiatives. Cardiovascular hospitalization rates were 30% higher among those living in remote and very remote areas than those in major cities of Australia, 5.6% of Australian adults had 1 or more -conditions related to the heart or vascular diseases including stroke, in 2017-2018. Also, the ongoing research activities by key players to develop technologically advanced cardiovascular drugs with reduced side effects such as biosimilars, monoclonal antibodies, and peptide therapies to save the life of the patients are expected to further boost the growth of the Australian cardiovascular disease market revenue throughout the forecast period.

Market Drivers

According to the Australian Bureau of Statistics (ABS), in 2017–18, the prevalence of heart, stroke, and vascular disease among adults (based on self-reported data). It was higher among men (6.5%) than women (4.8%) and it increased with age—more than 1 in 4 (26%) of those aged 75 and over had heart, stroke, and vascular disease.

The Cardiovascular Health Mission will invest $220 million over 10 years to bring together researchers, health professionals, industry, and patients to make transformative improvements in heart and vascular health and stroke for all Australians. There is an increase in people consuming drugs as they do not have to pay for the drugs, and this attracts more people to become aware and use their insurance policies for reimbursement of drugs.

 

1. Australian Cardiovascular Disease Market Overview…………………………………
A. Market Size
2. Market Growth Drivers……………………………………………..……………………….
A. Rise in Prevalence of Cardiac Disorders
B. Growing R&D Investments and Reimbursement Policies
3. Major Cardiovascular Diseases……………………………………………………….…
A. Hypertension
B. Hyperlipidaemia
C. Coronary Artery Disease
D. Arrhythmia
E. Others
4. Cardiovascular Therapeutics Market Segmentation……………………………………
A. Drug class
I. Anti-hyperlipidaemias
II. Anti-hypertensive
III. Anti-coagulants
IV. Anti-arrhythmic
V. Others
B. Distribution
I. Hospital pharmacy
II. Online Pharmacy
III. Retail Pharmacy
IV. others
5. Cardiovascular Disease Major Products Market Share…………………….…………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape…………………………………………….………….…………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles………………………………………………………………….
A. Abbott Laboratories overview, Product & Services, Strategies & Financials
B. Edwards Lifesciences Company overview, Product & Services, Strategies & Financials
C. Bristol- Myers Squibb Company overview, Product & Services, Strategies & Financials
D. Bayer AG Company overview, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape……………………………………
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth…………………………………………………………
A. New Trends and Development of Cardiovascular Disease market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

The Anti-coagulants in the drug class segment are expected to hold the largest market share in the cardiovascular drugs market. This dominance is due to the increased use of these drugs in various cardiac indications owing to their ability to reduce the risk of stroke and blood clots in people with atrial fibrillation, deep vein thrombosis (DVT), and pulmonary embolism (PE). On the other hand, anti-arrhythmic drugs are expected to lose the market due to the rise in the adoption of medical devices such as defibrillators and cardiac resynchronization therapy (CRT) pacemakers in recent years due to their automated acute hemodynamic response based on real-time changes in a patient’s cardiac condition.

Blood pressure-lowering medicines (such as perindopril and irbesartan) and blood cholesterol-lowering medicines (such as atorvastatin and rosuvastatin) were the most dispensed prescription medicines in Australia in 2015. In contrast, anti-hypertensives are anticipated to witness the fastest growth in the forecast period due to rising awareness among the patients and their rapid use in the prevention of severe complications such as stroke and myocardial infarction propelling the market growth across the forecast period.

By Distribution:

Based on the distribution channel, the market for cardiovascular drugs can be segmented into hospital pharmacies, retail pharmacies, pharmacies, and others. High incidences of hospital visits for cardiovascular disease consultation and rise in emergency department visits are likely to contribute to the steady growth of the hospital pharmacy segment.

Major Players

Key players covered in the Australian cardiovascular devices market are Medtronic plc, Abbott Laboratories, Boston Scientific Corporation, Cardinal Health Inc, Edwards Lifesciences. The major players for the cardiovascular drug market are Bristol- Myers Squibb Company, Pfizer Inc, Bayer AG, Janssen Pharmaceuticals Inc, and others.

 

 

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements